G. Kahn
Fortuna: 21 726 $ al 31/05/2026
Fortuna: 21 726 $ al 31/05/2026
G.
Clare Kahn is currently President at Clare Kahn Pharma Consulting LLC since 2016.
Independent Director at Solid Biosciences, Inc. since 2021.
Independent Director at Stoke Therapeutics, Inc. starting in 2026.
Formerly Vice President-Global Innovative Pharma at Pfizer Inc. from 2014 to 2016.
Vice President-Regulatory Affairs at GSK Plc from 1999 to 2010.
Chief Regulatory & Preclinical Development Officer at X-Vax Technology, Inc. from 2018 to 2019.
Assistant Professor at the University of Pennsylvania from 1981 to 1985.
Earned a doctorate from Royal Postgraduate Medical School in 1981.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 10/06/2026 | 2.960 ( 0 % ) | 21 726 $ | 31/05/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| SOLID BIOSCIENCES INC. | Director/Miembro de la Junta | 02/03/2021 |
| STOKE THERAPEUTICS, INC. | Director/Miembro de la Junta | 03/04/2026 |
Clare Kahn Pharma Consulting LLC | Presidente | 01/06/2016 |
| Empresas | Cargo | Fin |
|---|---|---|
| PFIZER INC. | Corporate Officer/Principal | 01/06/2016 |
| GSK PLC | Consejero General | 01/01/2010 |
University of Pennsylvania
University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | 01/01/1985 |
X-Vax Technology, Inc.
X-Vax Technology, Inc. BiotechnologyHealth Technology Develops biotechnology products | Director Técnico/Científico/I+D | - |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 8 |
|---|---|
Pfizer Inc.
Pfizer Inc. Pharmaceuticals: MajorHealth Technology Engages in discovery, development, manufacturing, marketing, sale and distribution of biopharmaceutical products & ingredients | Health Technology |
GSK Plc
GSK Plc Pharmaceuticals: MajorHealth Technology Develops, manufactures and distributes vaccines and other pharmaceutical products | Health Technology |
University of Pennsylvania
University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Solid Biosciences, Inc.
Solid Biosciences, Inc. BiotechnologyHealth Technology Operates as a pharmaceutical company that develops treatments through gene therapy for patients with duchenne disease | Health Technology |
X-Vax Technology, Inc.
X-Vax Technology, Inc. BiotechnologyHealth Technology Develops biotechnology products | Health Technology |
Stoke Therapeutics, Inc.
Stoke Therapeutics, Inc. BiotechnologyHealth Technology Operates as biotechnology company focused on the development of first-in-class therapeutics that selectively increase gene expression to treat genetic diseases | Health Technology |
Royal Postgraduate Medical School
Royal Postgraduate Medical School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Clare Kahn Pharma Consulting LLC |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.